{
    "opml": {
        "head": {
            "title": "miljko tweets",
            "dateCreated": "Sat, 29 Jan 2022 12:30:38 GMT",
            "expansionState": "1,2",
            "urlPublic": "http://tweets.opml.org/miljko/tweets.opml",
            "urlUpdateSocket": "ws://tweets.opml.org:1481/",
            "dateModified": "Wed, 02 Mar 2022 18:57:47 GMT"
        },
        "body": {
            "subs": [
                {
                    "text": "March 2022",
                    "type": "calendarMonth",
                    "name": "march2022",
                    "subs": [
                        {
                            "text": "March 2",
                            "type": "calendarDay",
                            "name": "02",
                            "subs": [
                                {
                                    "text": "@ManniMD1 @oncology_bg @AaronGoodman33 @VPrasadMDMPH Yep, that paragraph was exactly what I had in mind! Do you have names of the drugs tested as part of the dataset? That could help answer the question.",
                                    "rawText": "@ManniMD1 @oncology_bg @AaronGoodman33 @VPrasadMDMPH Yep, that paragraph was exactly what I had in mind! Do you have names of the drugs tested as part of the dataset? That could help answer the question.",
                                    "type": "tweet",
                                    "created": "Wed, 02 Mar 2022 18:50:47 GMT",
                                    "tweetId": "1499094885256859651",
                                    "urltweet": "https://twitter.com/miljko/status/1499094885256859651",
                                    "inReplyToId": "1499093688978317314",
                                    "tweetUserName": "miljko"
                                },
                                {
                                    "text": "@ManniMD1 @oncology_bg @AaronGoodman33 @VPrasadMDMPH Interesting. The Wesson review (<a href=\"https://t.co/8hPhONLCrN\">[link]</a>) doesn't note the type of non-randomized trials that increased from 2015 to 2020, so hard to see why their explanation of decreased randomization should be accepted over something less nefarious, like more drugs being tested",
                                    "rawText": "@ManniMD1 @oncology_bg @AaronGoodman33 @VPrasadMDMPH Interesting. The Wesson review (https://t.co/8hPhONLCrN) doesn't note the type of non-randomized trials that increased from 2015 to 2020, so hard to see why their explanation of decreased randomization should be accepted over something less nefarious, like more drugs being tested",
                                    "type": "tweet",
                                    "created": "Wed, 02 Mar 2022 18:40:09 GMT",
                                    "tweetId": "1499092209743843341",
                                    "urltweet": "https://twitter.com/miljko/status/1499092209743843341",
                                    "inReplyToId": "1499010950204047361",
                                    "tweetUserName": "miljko"
                                }
                            ]
                        },
                        {
                            "text": "March 1",
                            "type": "calendarDay",
                            "name": "01",
                            "subs": [
                                {
                                    "text": "Sve sam skoro bodove imao, poljoprivrednu školu… legalizovao objekte, godine… Sve sam imao, jednostavno… sklonili su me, nisam prošao\n-Zašto?\nMislim zato što nisam bio u stranci… Ne znam, sve je to… zna se to unapred ko će da prođe.\n-Hoćeš ponovo konkurisati?\nNe, nikad više. <a href=\"https://t.co/bZgFdh2wQe\">[link]</a>",
                                    "rawText": "Sve sam skoro bodove imao, poljoprivrednu školu… legalizovao objekte, godine… Sve sam imao, jednostavno… sklonili su me, nisam prošao\n-Zašto?\nMislim zato što nisam bio u stranci… Ne znam, sve je to… zna se to unapred ko će da prođe.\n-Hoćeš ponovo konkurisati?\nNe, nikad više. https://t.co/bZgFdh2wQe",
                                    "type": "tweet",
                                    "created": "Tue, 01 Mar 2022 16:24:13 GMT",
                                    "tweetId": "1498695613034254336",
                                    "urltweet": "https://twitter.com/miljko/status/1498695613034254336",
                                    "tweetUserName": "miljko"
                                },
                                {
                                    "text": "@nntaleb @SwenRoschlau @lexfridman Seeing members of his security council grovel makes me wonder about the many people who need to approve.\nI also wouldn’t discount the possibility of a screwup on the US side\nYou can make up stories about why it wouldn’t happen, but he increased the chance of it happening in error",
                                    "rawText": "@nntaleb @SwenRoschlau @lexfridman Seeing members of his security council grovel makes me wonder about the many people who need to approve.\nI also wouldn’t discount the possibility of a screwup on the US side\nYou can make up stories about why it wouldn’t happen, but he increased the chance of it happening in error",
                                    "type": "tweet",
                                    "created": "Tue, 01 Mar 2022 12:55:23 GMT",
                                    "tweetId": "1498643061387280387",
                                    "urltweet": "https://twitter.com/miljko/status/1498643061387280387",
                                    "inReplyToId": "1498627912932773890",
                                    "tweetUserName": "miljko"
                                }
                            ]
                        }
                    ]
                }
            ]
        }
    }
}